Incidence of systemic inflammatory response syndrome and patient outcome following transcatheter edge-to-edge mitral valve repair

[1] Otto CM(2021)2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: a Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines Circulation 143 e72-e227

[2] Nishimura RA(2022)Trends in transcatheter edge-to-edge mitral valve repair over a decade: data from the MiTra ULM Registry Front Cardiovasc Med 9 Iii95-Iii100

[3] Bonow RO(2000)Humoral immune response during coronary artery bypass grafting: a comparison of limited approach, "off-pump" technique, and conventional cardiopulmonary bypass Circulation 102 365-370

[4] Carabello BA(2003)Systemic inflammatory response syndrome after cardiac surgery under cardiopulmonary bypass Ann Thorac Cardiovasc Surg 9 1643-1650

[5] Erwin JP(2005)Systemic inflammatory response syndrome after acute myocardial infarction complicated by cardiogenic shock Arch Intern Med 165 232-244

[6] Gentile F(2002)Cardiopulmonary bypass induced inflammation: pathophysiology and treatment. An update Eur J Cardiothorac Surg 21 1682-1690

[7] Nita N(2019)Prevalence and clinical impact of systemic inflammatory reaction after cardiac surgery J Cardiothorac Vasc Anesth 33 1459-1468

[8] Schneider L(2012)Systemic inflammatory response syndrome predicts increased mortality in patients after transcatheter aortic valve implantation Eur Heart J 33 1468-1473

[9] Dahme T(2015)Occurrence and prognostic impact of systemic inflammatory response syndrome in transfemoral and transapical aortic valve implantation with balloon- and self-expandable valves EuroIntervention 10 2134-2140

[10] Markovic S(2005)Percutaneous mitral valve repair using the edge-to-edge technique: six-month results of the EVEREST Phase I Clinical Trial J Am Coll Cardiol 46 1-39

[1] Otto CM(2021)2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: a Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines Circulation 143 e72-e227

[2] Nishimura RA(2022)Trends in transcatheter edge-to-edge mitral valve repair over a decade: data from the MiTra ULM Registry Front Cardiovasc Med 9 Iii95-Iii100

[3] Bonow RO(2000)Humoral immune response during coronary artery bypass grafting: a comparison of limited approach, "off-pump" technique, and conventional cardiopulmonary bypass Circulation 102 365-370

[4] Carabello BA(2003)Systemic inflammatory response syndrome after cardiac surgery under cardiopulmonary bypass Ann Thorac Cardiovasc Surg 9 1643-1650

[5] Erwin JP(2005)Systemic inflammatory response syndrome after acute myocardial infarction complicated by cardiogenic shock Arch Intern Med 165 232-244

[6] Gentile F(2002)Cardiopulmonary bypass induced inflammation: pathophysiology and treatment. An update Eur J Cardiothorac Surg 21 1682-1690

[7] Nita N(2019)Prevalence and clinical impact of systemic inflammatory reaction after cardiac surgery J Cardiothorac Vasc Anesth 33 1459-1468

[8] Schneider L(2012)Systemic inflammatory response syndrome predicts increased mortality in patients after transcatheter aortic valve implantation Eur Heart J 33 1468-1473

[9] Dahme T(2015)Occurrence and prognostic impact of systemic inflammatory response syndrome in transfemoral and transapical aortic valve implantation with balloon- and self-expandable valves EuroIntervention 10 2134-2140

[10] Markovic S(2005)Percutaneous mitral valve repair using the edge-to-edge technique: six-month results of the EVEREST Phase I Clinical Trial J Am Coll Cardiol 46 1-39